Metronomic Chemotherapy for Advanced Prostate Cancer: A Literature Review

Metastatic castration-resistant prostate cancer (mCRPC) is the ultimately lethal form of prostate cancer. Docetaxel chemotherapy was the first life-prolonging treatment for mCRPC; however, the standard maximally tolerated dose (MTD) docetaxel regimen is often not considered for patients with mCRPC w...

Descripción completa

Detalles Bibliográficos
Autores principales: Parshad, Shruti, Sidhu, Amanjot K., Khan, Nabeeha, Naoum, Andrew, Emmenegger, Urban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147851/
https://www.ncbi.nlm.nih.gov/pubmed/35628909
http://dx.doi.org/10.3390/jcm11102783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147851/
https://www.ncbi.nlm.nih.gov/pubmed/35628909
http://dx.doi.org/10.3390/jcm11102783

Ejemplares similares